Long-Term Regulation of Potassium Channels
钾通道的长期调节
基本信息
- 批准号:7047452
- 负责人:
- 金额:$ 37.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-12-20 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:NAD(P)H dehydrogenaseangiotensin IIapoptosiscardiac myocytescardiovascular functionelectrophysiologyenzyme activityfree radical oxygenhigh throughput technologylaboratory ratmembrane proteinsneuronsneurophysiologyphosphorylationpotassium channelprotein structure functionsingle cell analysistissue /cell culturevascular smooth musclevoltage gated channel
项目摘要
DESCRIPTION (provided by applicant): Potassium channels control the function of excitable cells such as neurons, smooth muscle cells and cardiac myocytes. Potassium channel regulation is also important in programmed cell death in a variety of cell types. Although a great deal is understood about the function and acute modulation of potassium channels, little is known about long-term control of potassium channel function. Yet, manipulating potassium channel expression in vascular smooth muscle cells, cardiac myocytes and neurons could be a valuable therapeutic approach for controlling high blood pressure and reducing the incidence of cardiac arrhythmias and epileptic seizures. Here we pursue three aims focused on our ongoing studies of potassium channel expression and activity. Aim 1 will determine how Angiotensin II (Ang II) acts on cardiac myocytes to downregulate Kv4.3 channel expression. Experiments will test the hypothesis Ang II acts via NADPH oxidase- generated reactive oxygen species (ROS) to destabilize the 3' untranslated region of the channel messenger RNA. Aim 2 will determine how a protein and a chemical identified by high throughput screening stimulate Kir2.1 activity. Since total channel expression is unaffected, experiments will focus on whether these two activators affect channel trafficking and function. Aim 3 will determine how voltage-gated potassium (Kv) channel activity is slowly increased as a critical step in apoptosis. We will determine whether phosphorylation triggers insertion of new homomeric Kv2.1 channels in the cell surface. Furthermore, we will test whether native channels found in vascular smooth muscle and the heart are subject to similar regulation. This proposal will reveal fundamental insights into novel physiological, pharmacological and pathological mechanisms that produce long-term regulation of potassium channel activity in the heart, blood vessels and the brain.
描述(申请人提供):钾通道控制神经元、平滑肌细胞和心肌细胞等兴奋性细胞的功能。钾通道调节在多种细胞类型的细胞程序性死亡中也是重要的。虽然人们对钾通道的功能和急性调节有了很多了解,但对钾通道功能的长期调控知之甚少。然而,调控血管平滑肌细胞、心肌细胞和神经元的钾通道表达可能是控制高血压、减少心律失常和癫痫发作的一种有价值的治疗方法。在这里,我们追求三个目标,专注于我们正在进行的钾通道表达和活性的研究。目的1确定血管紧张素II(Ang II)如何作用于心肌细胞以下调Kv4.3通道的表达。实验将验证Ang II通过NADPH氧化酶产生的活性氧物种(ROS)作用于破坏通道信使RNA的3‘非翻译区稳定的假设。目标2将确定高通量筛选确定的蛋白质和化学物质如何刺激Kir2.1活性。由于总的通道表达不受影响,实验将集中在这两个激活剂是否影响通道交易和功能。目标3将确定电压门控钾(Kv)通道活性是如何缓慢增加的,作为细胞凋亡的关键步骤。我们将确定磷酸化是否触发在细胞表面插入新的同源Kv2.1通道。此外,我们将测试在血管平滑肌和心脏中发现的天然通道是否受到类似的调节。这一提议将揭示对心脏、血管和大脑中钾通道活动产生长期调节的新的生理、药理学和病理机制的基本见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWIN S LEVITAN其他文献
EDWIN S LEVITAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWIN S LEVITAN', 18)}}的其他基金
A New Method for Imaging Neuropeptide Release in the Brain
大脑中神经肽释放成像的新方法
- 批准号:
10016856 - 财政年份:2019
- 资助金额:
$ 37.13万 - 项目类别:
Endoplasmic Reticulum NAD(P)H Dynamics in Dopamine Neurons
多巴胺神经元内质网 NAD(P)H 动力学
- 批准号:
9750034 - 财政年份:2018
- 资助金额:
$ 37.13万 - 项目类别:
Antipsychotic Drug Vesicular Release at Dopamine Synapses
多巴胺突触的抗精神病药物囊泡释放
- 批准号:
9125571 - 财政年份:2016
- 资助金额:
$ 37.13万 - 项目类别:
Antipsychotic Drug Vesicular Release at Dopamine Synapses
多巴胺突触的抗精神病药物囊泡释放
- 批准号:
9273637 - 财政年份:2016
- 资助金额:
$ 37.13万 - 项目类别:
Multiphoton detection of dopamine and drug release
多巴胺和药物释放的多光子检测
- 批准号:
8780111 - 财政年份:2014
- 资助金额:
$ 37.13万 - 项目类别:
Multiphoton Monoamine Imaging of Serotonin Neuron Function
血清素神经元功能的多光子单胺成像
- 批准号:
7674555 - 财政年份:2008
- 资助金额:
$ 37.13万 - 项目类别:
Multiphoton Monoamine Imaging of Serotonin Neuron Function
血清素神经元功能的多光子单胺成像
- 批准号:
7570447 - 财政年份:2008
- 资助金额:
$ 37.13万 - 项目类别:
相似海外基金
Mapping the Angiotensin II-TGFB-Integrin signaling triad to reveal therapeutic targets in aortic aneurysm
绘制血管紧张素 II-TGFB-整合素信号三联体图谱以揭示主动脉瘤的治疗靶点
- 批准号:
9108213 - 财政年份:2016
- 资助金额:
$ 37.13万 - 项目类别:
Mapping the Angiotensin II-TGFB-Integrin signaling triad to reveal therapeutic targets in aortic aneurysm
绘制血管紧张素 II-TGFB-整合素信号三联体图谱以揭示主动脉瘤的治疗靶点
- 批准号:
9274098 - 财政年份:2016
- 资助金额:
$ 37.13万 - 项目类别:
Angiotensin II Modulates Hypertrophic Differentiation and Apoptosis of Chondrocytes: Relationship of hypertension to Osteoarthrosis
血管紧张素 II 调节软骨细胞的肥大分化和凋亡:高血压与骨关节病的关系
- 批准号:
26460928 - 财政年份:2014
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Intrarenal Angiotensin II generation during Angiotensin II-induced hypertension
血管紧张素 II 诱导的高血压期间肾内血管紧张素 II 的生成
- 批准号:
8299620 - 财政年份:2011
- 资助金额:
$ 37.13万 - 项目类别:
Intrarenal Angiotensin II generation during Angiotensin II-induced hypertension
血管紧张素 II 诱导的高血压期间肾内血管紧张素 II 的生成
- 批准号:
8515909 - 财政年份:2011
- 资助金额:
$ 37.13万 - 项目类别:
Balance of Angiotensin II/Angiotensin (1-1): A Target in Ischemic Stroke
血管紧张素 II/血管紧张素 (1-1) 的平衡:缺血性中风的目标
- 批准号:
8111079 - 财政年份:2010
- 资助金额:
$ 37.13万 - 项目类别:
Balance of Angiotensin II/Angiotensin (1-1): A Target in Ischemic Stroke
血管紧张素 II/血管紧张素 (1-1) 的平衡:缺血性中风的目标
- 批准号:
7986756 - 财政年份:2010
- 资助金额:
$ 37.13万 - 项目类别:
Balance of Angiotensin II/Angiotensin (1-1): A Target in Ischemic Stroke
血管紧张素 II/血管紧张素 (1-1) 的平衡:缺血性中风的目标
- 批准号:
8268989 - 财政年份:2010
- 资助金额:
$ 37.13万 - 项目类别:
Balance of Angiotensin II/Angiotensin (1-1): A Target in Ischemic Stroke
血管紧张素 II/血管紧张素 (1-1) 的平衡:缺血性中风的目标
- 批准号:
8476257 - 财政年份:2010
- 资助金额:
$ 37.13万 - 项目类别:
Angiotensin II, IGF-1 and Skeletal Muscle Atrophy
血管紧张素 II、IGF-1 和骨骼肌萎缩
- 批准号:
7339832 - 财政年份:2007
- 资助金额:
$ 37.13万 - 项目类别: